1
|
Yuan S, Zhu Y, Dai Y, Wang Y, Jin D, Liu M, Tang L, Arnesano F, Natile G, Liu Y. 19
F NMR Allows the Investigation of the Fate of Platinum(IV) Prodrugs in Physiological Conditions. Angew Chem Int Ed Engl 2022. [DOI: 10.1002/ange.202114250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Siming Yuan
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Yang Zhu
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Yi Dai
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Yu Wang
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Duo Jin
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Manman Liu
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Liqin Tang
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| | - Fabio Arnesano
- Dipartimento di Chimica Università di Bari “A. Moro” via E. Orabona 4 70125 Bari Italy
| | - Giovanni Natile
- Dipartimento di Chimica Università di Bari “A. Moro” via E. Orabona 4 70125 Bari Italy
| | - Yangzhong Liu
- Department of Pharmacy, the First Affiliated Hospital of USTC Division of Life Sciences and Medicine Department of Chemistry University of Science and Technology of China Hefei Anhui China
| |
Collapse
|
2
|
Yuan S, Zhu Y, Dai Y, Wang Y, Jin D, Liu M, Tang L, Arnesano F, Liu Y, Natile G. 19F NMR Allows to Investigate the Fate of Platinum(IV) Prodrugs in Physiological Conditions. Angew Chem Int Ed Engl 2021; 61:e202114250. [PMID: 34800083 DOI: 10.1002/anie.202114250] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Indexed: 11/11/2022]
Abstract
Pt(IV) prodrugs can overcome resistance and side effects of conventional Pt(II) anticancer therapies. By 19 F-labeling of a Pt(IV) prodrug (Pt-FBA, FBA = p -fluorobenzoate), the activation under physiological conditions could be investigated. It is found that, unlike single-electron reductants, multi-electron agents can efficiently promote the two electrons reduction of Pt(IV) to Pt(II). Moreover, the activation of Pt-FBA in cell lysate is highly dependent upon the type of cancer cells. When administered to E. coli , Pt-FBA is reduced intracellularly and free FBA can shuttle out of the cell. Interestingly, the reduction rate greatly increases by inducing metallothionein overexpression and is lowered by addition of Zn(II) ions. Finally, when injected into mice, Pt-FBA undergoes fast reduction in the bloodstream accompanied by metabolic degradation of FBA; nevertheless, unreduced Pt-FBA can accumulate to detectable levels in liver and kidneys. The proposed 19 F-NMR approach has the advantage of avoiding the interference of all background signals.
Collapse
Affiliation(s)
- Siming Yuan
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Yang Zhu
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Yi Dai
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Yu Wang
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Duo Jin
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Manman Liu
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Liqin Tang
- University of Science and Technology of China, The First Affiliated Hospital of USTC, CHINA
| | - Fabio Arnesano
- University of Bari: Universita degli Studi di Bari Aldo Moro, Department of Chemistry, ITALY
| | - Yangzhong Liu
- University of Science and Technology of China, Department of Chemistry, CHINA
| | - Giovanni Natile
- University of Bari, Department of Chemistry, Via E. Orabona 4, 70125, Bari, ITALY
| |
Collapse
|
3
|
Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action. Molecules 2020; 25:molecules25215167. [PMID: 33171980 PMCID: PMC7664195 DOI: 10.3390/molecules25215167] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 10/31/2020] [Accepted: 11/01/2020] [Indexed: 12/13/2022] Open
Abstract
Platinum-based anticancer drugs are a class of widely used agents in clinical cancer treatment. However, their efficacy was greatly limited by their severe side effects and the arising drug resistance. The selective activation of inert platinum-based drugs in the tumor site by light irradiation is able to reduce side effects, and the novel mechanism of action of photoactivatable platinum drugs might also conquer the resistance. In this review, the recent advances in the design of photoactivatable platinum-based drugs were summarized. The complexes are classified according to their mode of action, including photoreduction, photo-uncaging, and photodissociation. The rationale of drug design, dark stability, photoactivation process, cytotoxicity, and mechanism of action of typical photoactivatable platinum drugs were reviewed. Finally, the challenges and opportunities for designing more potent photoactivatable platinum drugs were discussed.
Collapse
|
4
|
Shi H, Imberti C, Sadler PJ. Diazido platinum(iv) complexes for photoactivated anticancer chemotherapy. Inorg Chem Front 2019. [DOI: 10.1039/c9qi00288j] [Citation(s) in RCA: 60] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Diazido Pt(iv) complexes with a general formula [Pt(N3)2(L)(L′)(OR)(OR′)] are a new generation of anticancer prodrugs designed for use in photoactivated chemotherapy.
Collapse
Affiliation(s)
- Huayun Shi
- Department of Chemistry
- University of Warwick
- Coventry
- UK
| | | | | |
Collapse
|
5
|
Abstract
The success of platinum-based anticancer agents has motivated the exploration of novel metal-based drugs for several decades, whereas problems such as drug-resistance and systemic toxicity hampered their clinical applications and efficacy. Stimuli-responsiveness of some metal complexes offers a good opportunity for designing site-specific prodrugs to maximize the therapeutic efficacy and minimize the side effect of metallodrugs. This review presents a comprehensive and up-to-date overview on the therapeutic stimuli-responsive metallodrugs that have appeared in the past two decades, where stimuli such as redox, pH, enzyme, light, temperature, and so forth were involved. The compounds are classified into three major categories based on the nature of stimuli, that is, endo-stimuli-responsive metallodrugs, exo-stimuli-responsive metallodrugs, and dual-stimuli-responsive metallodrugs. Representative examples of each type are discussed in terms of structure, response mechanism, and potential medical applications. In the end, future opportunities and challenges in this field are tentatively proposed. With diverse metal complexes being introduced, the foci of this review are pointed to platinum and ruthenium complexes.
Collapse
Affiliation(s)
- Xiaohui Wang
- College of Chemistry and Molecular Engineering , Nanjing Tech University , Nanjing 211816 , P. R. China
| | - Xiaoyong Wang
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences , Nanjing University , Nanjing 210023 , P. R. China
| | - Suxing Jin
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences , Nanjing University , Nanjing 210023 , P. R. China
| | - Nafees Muhammad
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry , Sun Yat-Sen University , Guangzhou 510275 , P. R. China
| | - Zijian Guo
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering , Nanjing University , Nanjing 210093 , P. R. China
| |
Collapse
|
6
|
Harper BWJ, Friedman-Ezra A, Sirota R, Petruzzella E, Aldrich-Wright JR, Gibson D. Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its Pt IV Derivatives with Human Serum. ChemMedChem 2017; 12:510-519. [PMID: 28206707 DOI: 10.1002/cmdc.201700092] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Indexed: 12/25/2022]
Abstract
The discrepancy between the in vitro cytotoxic results and the in vivo performance of Pt56MeSS prompted us to look into its interactions and those of its PtIV derivatives with human serum (HS), human serum albumin (HSA), lipoproteins, and serum-supplemented cell culture media. The PtII complex, Pt56MeSS, binds noncovalently and reversibly to slow-tumbling proteins in HS and in cell culture media and interacts through the phenanthroline group with HSA, with a Kd value of ∼1.5×10-6 m. All PtIV complexes were found to be stable toward reduction in HS, but those with axial carboxylate ligands, cct-[Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenantroline)(acetato)2 ](TFA)2 (Pt56MeSS(OAc)2 ) and cct-[Pt(1S,2S-DACH)(5,6-dimehtyl-1,10-phenantroline)(phenylbutyrato)2 ](TFA)2 (Pt56MeSS(PhB)2 ), were spontaneously reduced at pH 7 or higher in phosphate buffer, but not in Tris buffer (pH 8). HS also decreased the rate of reduction by ascorbate of the PtIV complexes relative to the reduction rates in phosphate buffer, suggesting that for this compound class, phosphate buffer is not a good model for HS.
Collapse
Affiliation(s)
- Benjamin W J Harper
- Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel
| | - Aviva Friedman-Ezra
- Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel
| | - Roman Sirota
- Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel
| | - Emanuele Petruzzella
- Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel
| | - Janice R Aldrich-Wright
- School of Science and Health, Western Sydney University, Penrith South DC, 1797, NSW, Australia
| | - Dan Gibson
- Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel
| |
Collapse
|
7
|
Abstract
Platinum-based chemotherapeutic drugs such as cisplatin, carboplatin and oxaliplatin are widely applied for the treatment of various types of tumours. Over the last few decades, a large variety of Pt(II) and Pt(IV) complexes have been developed to improve the applicability in a wider spectrum of cancers, increase their therapeutic window and reduce the dose-limiting side effects. Photodynamic therapy (PDT), which is the administration of a photosensitiser followed by visible light activation, is a promising route to avoid damage to healthy cells and the surrounding tissue. Transition metal complexes as photochemotherapeutic agents are an attractive option for further development in the field of photoactivated chemotherapy (PACT). These complexes exhibit different numbers and types of excited states which are easily accessible upon light irradiation, subsequently giving rise to the formation of various photoproducts that can enable a distinct mode of action. Platinum-diazido complexes are promising candidates for PACT due to the low cytotoxicity when irradiated with visible light. This review summarises the mode of action of current platinum anticancer drugs with cisplatin as a lead example and the development of non-conventional Pt(II) complexes. Background information regarding PDT the photophysical and photochemical properties of metal complexes is provided, as well as notable examples of photoactivated metal complexes with biological activity. Particular emphasis is placed on recent developments on platinum photoactivated drugs.
Collapse
|
8
|
Zhao Y, Roberts GM, Greenough SE, Farrer NJ, Paterson MJ, Powell WH, Stavros VG, Sadler PJ. Two-Photon-Activated Ligand Exchange in Platinum(II) Complexes. Angew Chem Int Ed Engl 2012; 51:11263-6. [DOI: 10.1002/anie.201206283] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2012] [Indexed: 11/10/2022]
|
9
|
Zhao Y, Roberts GM, Greenough SE, Farrer NJ, Paterson MJ, Powell WH, Stavros VG, Sadler PJ. Two-Photon-Activated Ligand Exchange in Platinum(II) Complexes. Angew Chem Int Ed Engl 2012. [DOI: 10.1002/ange.201206283] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
10
|
Loakes D. Nucleotides and nucleic acids; oligo- and polynucleotides. ORGANOPHOSPHORUS CHEMISTRY 2012. [DOI: 10.1039/9781849734875-00169] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Affiliation(s)
- David Loakes
- Medical Research Council Laboratory of Molecular Biology, Hills Road Cambridge CB2 2QH UK
| |
Collapse
|
11
|
Suntharalingam K, Vilar R. Interaction of metal complexes with nucleic acids. ACTA ACUST UNITED AC 2011. [DOI: 10.1039/c1ic90027g] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|